Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
89 participants
INTERVENTIONAL
2020-06-15
2022-07-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study was conducted on 89 patients aged 6-12 years who had caries on bilateral mandibular first molars. Our study has a randomized, cross-controlled, and double-blind design. In split-mouth design, restorations of mandibular permanent molars completed with nano-hybrid ORMOCER based bulk-fill filling material Admira Fusion x-tra (Voco GmbH, Cuxhaven, Germany) and nano-hybrid composite Grandio (Voco , Cuxhaven, Germany). Futurabond U single dose (Voco, Cuxhaven, Germany) universal adhesive was used for all restorations, in the selective enamel etching mode. The clinical success of the restorations will be evaluated at 6, 12 and 24-month controls. Evaluations has been made by two physicians other than the one who did the restoration, who do not know which restorative material was applied to which tooth.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of Resin-modified Glass Ionomer and Composite Restorations in Permanent Teeth
NCT05583682
Twenty-Four-Month Clinical Comparison of Two Bulk-Fill and Microhybrid Composite Restorations
NCT04306549
Clinical Evaluation of Extensive Direct Composite Restorations With Polyethylene Fiber
NCT04612543
Evaluation of ART Restorations Using Two Different Bulk-Fill Restorative Materials in Primary Molars
NCT06771362
Could Bulk Fill Glass Hybrid Restorative Materials Replace Composite Resins in Treating Permanent Teeth?
NCT05551130
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bulk-fill composite resin
Bulk-fill Ormocer composite resin restorations on the mandibular first molars applied in layers of 4 mm depth
Bulk-fill composite resin
Restoration of the mandibular first molars with bulk-fill composite resin as the manufacturer advises after the cavity preparation
Nano-fill composite resin
Nano-fill composite resin restorations on the mandibular first molars were applied in layers of 2 mm depth
Nano-fill composite resin
Restoration of the mandibular first molars with nano-fill composite resin as the manufacturer advises after the cavity preparation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bulk-fill composite resin
Restoration of the mandibular first molars with bulk-fill composite resin as the manufacturer advises after the cavity preparation
Nano-fill composite resin
Restoration of the mandibular first molars with nano-fill composite resin as the manufacturer advises after the cavity preparation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* plaque index (Silnes and Löe, 1964) scores of the teeth to be processed was 0 and 1
* the gingival index (Löe and Silness, 1963) score was 0
Exclusion Criteria
* The values accepted in the evaluation of radiographic dental caries in the teeth for which the procedure is planned are E0-R0 (no radiolucency), E1-RA1 (radiolucency in the upper ½ of the enamel), E2-RA2 (radiolucency extending to the radiolucency-enamel-dentin junction in the lower ½ of the enamel) , with D1-RA3 (radiolucency observed in the upper 1/3 of the dentin),
* Non-antagonist of the teeth to be processed,
* In the gingival region of the teeth to be treated, there are areas covered with plaque from thin to medium thickness (plaque index score 2) and areas where the plaque thickness fills the gingival sulcus and where the soft attachment is high (plaque index score 3) (Löe and Silness, 1964),
* Bleeding and inflammation in the gingiva of the tooth to be treated (gingival index score (Löe and Silness, 1963) 1,2 and 3),
* Devitalized teeth for which the procedure is planned,
* The patient's lack of cooperation and physician cooperation to have the procedures performed (Score 1 and 2 on the Frankl behavioral scale).
* Having any systemic disease that prevents the treatment (ASA 2,3,4,5,6)
* Patients who will not comply with their appointments will not be included in the study
6 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Izmir Katip Celebi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Funda Cagırır Dindaroglu
Asst. Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Izmir Katip Celebi University
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E.728477
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.